Studies on the treatment of malignant tumors with fibroblast-inhibiting agent. I. Fibroblast-inhibiting action of chloroquine by Hiraki, Kiyoshi & Kimura, Ikuro
Acta Medica Okayama
Volume 17, Issue 5 1963 Article 3
1963
Studies on the treatment of malignant tumors
with fibroblast-inhibiting agent. I.
Fibroblast-inhibiting action of chloroquine
Kiyoshi Hiraki∗ Ikuro Kimura†
∗Okayama University,
†Okayama University,
Copyright c©1999 OKAYAMA UNIVERSITY MEDICAL SCHOOL. All rights reserved.
Studies on the treatment of malignant tumors
with fibroblast-inhibiting agent. I.
Fibroblast-inhibiting action of chloroquine∗
Kiyoshi Hiraki and Ikuro Kimura
Abstract
The effects of chloroquine on the growth and morphology of fibroblasts in tissue culture, and
in vivo granulomas were investigated. As the result, the drug was shown to have a potent action to
inhibit fibroblast growth, which has led to a possibility of its clinical use to patients with malignant
tumors.
∗PMID: 14165348 [PubMed - OLDMEDLINE] Copyright c©OKAYAMA UNIVERSITY MEDI-
CAL SCHOOL
Acta Med. Okayama 17, 231-238 (1963)
STUDIES ON THE TREATMENT OF MALIGNANT TUMORS
WITH FIBROBLAST-INHIBITING AGENT
I. FIBROBLAST-INHIBITING ACTION OF CHLOROQUINE
Kiyoshi HIRAKI and Ikuro KIMURA
Department of Internal Medicine, Okayama University Medical School
(Director: Prof. K. Hiraki)
Received for publication, August 10, i963
Malignant tumors consist of the parenchyma and stroma whose intimate
associated growth forms neoplasms. This association of the two elements are
also seen in the metastatic tumors. Our attention has been directed to the role of
the stromal tissue in supporting cancer cell as already pointed out by FISCHER1
and on the basis of our idea that damage of the stromal tissue might secondarily
results in damage of the cancer cells we have been conducting experimental
and clinical studies with animal and human tumors for the past several years.
To our best knowledge, no attempt has yet been made to approach malignant
tumors from this chemotherapeutic point of view.
Chloroquine, a derivative of quinoline, was used as the agent having a
fibroblast-inhibiting action (an action inhibiting growth of fibroblasts), as already
been recognized by HABERLAND.2 We have employed this agent, because it was
shown to exert a powerful fibroblast-inhibiting effect. It is the intent of this
paper to report our experimental results indicating the fibroblast-inhibiting effect
of chloroquine (Fig. 1).
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7-chloro-4-{4'-diethylamino·l'-methylbutylamino)-quinoline
Fig. 1 Structure of chloroquine
MATERIALS AND METHODS
To determine the degree of fibroblast-inhibiting effects of chloroquine, a
study was made on the influences of this drug upon the growth and morphology
of in vitro cultured chick embryo heart fibroblasts, in vivo agar granuloma, and
granuloma pouch of the animal.
Chick embryo heart fibroblasts were cultured on tissue culture slides No. 2
devised by HlRAKI3 ; cells taken from heart of 9-day·old chick embryos were
cultured in a medium consisting of an equal amount of chick embryo juice, avian
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serum and Ringer's solution, with addition of 5Y96, 500Y96, and 50,000Y 96 of
chloroquine diphosphate, respectively, and observation was performed at various
time intervals of 12, 24, 36, 48 and 72 hours with respect to the relative growth
rate and cell density index. The effects of other derivatives of chloroquine dioro-
tate, chloroquine chondroitin sulfate and chloroquine polygaracturonate were
compared at the chloroquine concentration of 2 Y96 with those of chloroquine
diphosphate at the same concentration.
For the observation of morphological changes of chick embryo heart fibro-
blasts, roller tubes implanted with rectangular coverslips were used; after 48
hours of culture, chloroquine diphosphate was added at the concentration of
200 Y % and phase contrast microscopy was performed after 72 hours in culture.
Agar granulomas were produced in the back of male Wistar rats by injecting
2 C.c. of 4 % agar solution in 1/10M phosphate buffer at pH 7.5 and beginning
after 24 hours, chloroquine diphosphate, chloroquine diorotate, chloroquine
chondroitin sulfate and chloroquine polygaracturonate were injected daily into the
tail vein in the net amount of chloroquine of 15 mg. per kg. of body weight.
After 15 days the animals were sacrificed and the granulomas were weighed and
examined histologically after being stained with hematoxylin and eosin and van
Gieson stain.
Similarly, granuloma pouches· were produced' in male Wistar rats by in-
jecting 25 C.c. of air subcutaneously in the back and by injecting 1 C.c. of 0.5 %
croton oil in corn oil into the air space. Daily intraperitoneal injection of 25 mg
of chloroquine diphosphate per kg. of body weight was started after 24 hours
and continued for 14 days. When the animals were killed, the total pouch
weight, weight of the pouch wall, amount of the exudate, and cell count in the
exudate were measured. In addition, the amount of chloroquine of the pouch
wall was determined by the method of BRODIE.5
RESULTS
1. Effects of chloroquine on the growth of chick embryo heart fibroblasts
(Fig. 2): A decrease in the relative growth rate and cell density index was
observed in cultures grown in medium containing 50,000Y % and 500 Y% of
chloroquine diphosphate in comparison with the control. Even at the concentra-
tion of 5Y%, a moderate decrease in the relative growth rate was seen. Cultures
grown in the medium containing 2Y% of chloroquine in the form of chloroquine
disphosphate, chloroquine diorotate, chloroquine chondroitin sulfate and chloro-
quine polygaracturonate likewise showed similar depressive effects of the same
degree.
2. Morphological changes of chick embryo heart fibroblasts (Photos 1, 2):
In the control culture the cells were slender with cytoplasmic processes. The
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-- Control
.. Chloroquine diphosphate
- - - Chloroquine diorotate
- .. - .. - Chloroquine chondroitin sulfate
- . - . -. Chloroquine polygaracturonate
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Fig. 2 Relative growth rate of fibroblasts of chick embryo heart in
tissue culture added with various chloroquine derivatives
(2'1 % expressed in chloroquine concentration)
cell margin was regular and distinct. Many intracytoplasmic vacuoles were small
and uniform in size. There were many mitochondrias around the nuclei and in
the cytoplasmic process, and they were granular or rod-shaped. The nuclei were
oval and had distinct nuclear membrane and nucleoli. The cells cultured in the
chloroquine-containing medium, however, showed an increase in the number of
intracytoplasmic vacuoles which varied in size and characteristically contained
giant vacuoles apparently resulting from confluent smaller vacuoles. No other
significant changes were observed.
3. Effects of chloroquine on the growth of agar granulomas (Fig. 3, Photos
Weight of granuloma (gram)
2.0 2~5 ,.0
Chloroquine. diphosphate
Chloroquine diorotate
Chloroquine chondroitin
sulfate
Chloroquine
polygaracturonate
Control
Fig. 3 Effect of chloroquine on agar granuloma (Wistar strain ~ rat,
intravenous injection of 15 mg./kg. expressed in chloroquine dosage)
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3,4): In all the chloroquine-treated groups, there was a reduction in the weight
compared with the control. This was particularly striking in granulomas treated
with "chloroquine diphosphate. Histologically the connective tissue surrounding
the agar was thinly developed and van Gieson staining disclosed a poor forma~
tion of collagenous fibers in the treated group.
4. Effects of chloroquine" on granuloma pouches (Table 1, Fig. 4): The
weight of total granuloma pouches and of granuloma wall, amount of exudate
and cell counts were all less than those of untreated ones. This seemed to be
due to an anti-inflammatory action as well as action of the agent inhibiting
fibroblast growth. The amount of chloroquine extractable from these granuloma
tissue was found to be larger than that extractable from the normal subcutaneaus
tissue.
Table 1 Effect of chloroquine on granuloma pouch (continuous intraperitoneal
injection for 14 days of chloroquine diphosphate 25 mg./kg.)
Treated group Control
Number 2 3 4 5 6 1 2 3 4 5 6 7
4.0 4.0 2.0 3.2 2.5 3.2 3.5
Average 3.2
28.624.0 14.0 19.0 17.5 19.0 26.0
Average 21. 2
3.0 12.0 11.0 17.020.0 12.5
Average 12.6
0.8 1.7 2.6 3.4 1.7 1.8
Average 2.0
Total weight
(gram)
-------------------------------
Weight of wall
(gram)
Amount of
exudate (c. c.)
2.0 10.0 8.0 13.2 18.0 10.4
Average 10.3
24.0 19.2 11.6 15.4 14.4 15.222.0
Average 17.3
Cell number of 3.2 4.3 1.8 3.3 5.0 2.0
exudate (x 103/mm.3) Average 3.27
3.5 6.2 1.8 9.7 2.4 7.6 8.1
Average 5.61
Chloroquine concentration ('l'/gram)
Liver
Wall of pouch
Subcutaneous tissue
Exudate
Fig. 4 Chloroquine distribution in the rat with granuloma pouch formation
(continuous intraperitoneal injection for 14 days of chloroquine
diphosphate 25 mg./kg.)
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DISCUSSION
We first recognized excellent therapeutic effects of chloroquine on Wakana
di~se and bronchial asthma, and in the course of our investigation of the
mechanism of drug action, it has been shown that the drug also has a potent
fibroblast-inhibiting action.
The agent in a low concentration inhibited considerably the growth of fibre-
blasts in tissue culture and induced degenerative changes of these cells. The
experiment with agar granulomas demonstrated a moderate inhibitory action on
fibroblast growth in vivo. The drug was shown to have a similar action and
furthermore proved to be anti-inflammatory in the experiment using granuloma
pouches.
The experiments of HABERLAND'Z in which several anti-inflammatory agents
were tested for the action inhibiting fibroblast growth in tissue culture indicated
that chloroquine diphosphate completely inhibited the growth of the cultured
fibroblasts at the dilution of 1 : 40,000, namely at the concentration of one tenth
of phenylbutazone and prednisone inducing the sam eeffect. In our experiments
chloroquine suppressed the growth of fibroblasts at the concentration of as low
as 21 96 in tissue culture medium. This concentration is much lower than serum
peak concentrations determined by the method of BRODI~ after oral or intra-
venous administration of chloroquine in human beings.6 Therefore, oral ingestion
as well as intravenous injection of 250 mg. of chloroquine diphosphate produces
serum levels above the effective range necessary for the drug action. Accordingly,
to achieve higher serum concentrations, the drug was given intravenously to pati-
ents with malignant tumors, as will be referred to in its clinical application.
Our observations on the inhibitory action of chloroquine on fibroblast growth
in agar granulomas and granuloma pouches in vivo, along with its effects on
cotton pellet granulomas in the HABERLAND's experiments,2 have strongly suggested
a possible clinical usefulness of the drug in inhibiting the stromal tissue of malig-
nant tumors, which is our eventual aim. Clinically we have already observed a
fairly good effect of the drug on hepatic fibrosis. The anti-inflammatory action
of the agent as shown in the present experiment with granuloma pouches may
be advantageous to this aim. The fact that chloroquine distributed more in the
wall of granuloma pouches than in normal subcutaneous tissue may be regarded
as showing its affinity to the former, possibly influencing the metabolism of the
granulomatous tissue.
SUMMARY
The effects of chloroquine on the growth and morphology of fibroblasts in
tissue culture, and in vivo granulomas were investigated. As the result, the drug
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was shown to have a potent action to inhibit fibroblast growth, which has led
to a possibility of its clinical use to patients with malignant tumors.
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~Photo. 1 Normal fibrublasts of chick embryo heart <Phase contrast microscopy)
Photo. 2 Fibroblasts ot chick embryo heart grown in medium containing chloroquine diphosphate
(Phase contrast microscopy)
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Photo. 3 Agar granuJoma in untreated rat (H. & E. staining)
Photo. 4 Agar granuloma in rat given chloroquine diphosphate (H. & E. staining)
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